The morning of September 19, the eleventh China (Taizhou) International Medical Fair, Jiangsu epidemic prevention materials exhibition in Taizhou City, Jiangsu Province, China Medical City Convention and Exhibition Center opened. This medical fair by the China International Chamber of Commerce, the Chinese Academy of Traditional Chinese Medicine, Taizhou City People’s Government, the China Council for the Promotion of International Trade, Jiangsu Province Branch. The theme is “the epidemic under the development trend of medicine and health industry”, from September 19th to 21st.

This year’s medical fair adhere to the “exhibition with the meeting, will attract investment” principle of organizing the meeting, for enterprises seeking cooperation, provides a platform for sharing and exchange. This year’s exhibition set up a total of 605 booths, a total of 761 enterprises registered exhibitors, including from the United States, Belgium, France, Spain, Portugal, Greece, Italy, Britain, Japan, Russia, Germany and other countries in more than 20 countries. It is expected that 16,000 people will attend the exhibition.

Translated with DeepL.com (free version)

Nanjing Liming Bio-products Co., Ltd.
Hall E2, 1F: G~077
Nanjing Liming Bio-products Co., Ltd. was invited to participate as an anti-epidemic substance producer in Jiangsu Province, and set up a booth of nearly 20 square meters, displaying the company’s latest R&D achievements in new coronavirus detection, STD detection, intestinal disease detection, pregnancy detection, fungus detection, etc. In a comprehensive manner, the company attracted foreign trade distribution and exporting companies from Beijing, Shanghai, Zhejiang, and Guangzhou, etc., who stopped by to communicate and reached preliminary cooperation intentions.

 

As a biological diagnostic company specializing in the research and development of clinical microbiological in vitro diagnostic reagents, Nanjing Liming Bio-products Co., Ltd. actively responded to the call of the state after the outbreak of Xinguang Pneumonia, assumed its due responsibility and social commitment, and the company’s technical team of public relations researchers successively developed the Xinguang antibody, Xinguang nucleic acid and Xinguang antigen test reagents and obtained a number of international certificates, which are well-selling in many countries around the world, and contributed to the winning of the global war of prevention and control of the epidemic by its practical actions.